Molecular mechanisms of organ regeneration and homeoslasis by injurin/HGF system.
Molecular mechanisms of organ regeneration and homeoslasis by injurin/HGF system.
批准号:
05404080
负责人:
NAKAMURA Toshikazu
金额:
$20.29万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (A)
财政年份:
1993
资助国家:
日本
项目状态:
已结题
起止时间:
1993 至 1995
中文摘要
点击翻译按钮获取中文摘要
英文摘要
(1) Roles of HGF as an organotrophic factor : Recombinant HGF suppressed the onset of liver fibrosis/cirrhosis and fatty liver caused by chronic hepatic injury. We found that HGF functions as renotrophic and pulmotrophic factor for regeneration of the kidney and lung. HGF may well become a new therapeutic drug for the treatment of various organ diseases, including liver fibrosis/cirrhosis, acute renal failure, and lung fibrosis.(2) HGF as a neurotrophic factor : HGF stimulated survival of hippocampal neurons in vitro. Importantly, the infused recombinant HGF markedly prevented neuronal death caused by ischemic injury in rats.(3) HGF as a mediator in epithelial-mesenchymal interactions : Epithelial-mesenchymal interaction is a critical tissue interaction for organogenesis. HGF is expressed in mesenchymal tissue, while c-Met/HGF receptor in epithelial tissue during development of the liver, kidney, lung tooth, limb, etc. HGF supports organogenesis of various organs, such as the liver, kidney, lung, tooth, mammary gland, as a mesenchymal-derived factor.(4) HGF is tumor-stromal interactions : Malignant phenotypes of tumor cells are regulated through their interactions with host stromal cells. We found that various tumor cells produce HGF-inducer (injurin) and stromal-derived HGF enhanced the invation of tumor cells. Matual interaction between tumor cells and host stromal cells mediate tumor-stromal interactions.(5) Identification of injurin (HGF-inducer) : We purified injurin (s) from lung tissue extract and found that these are IL-1, PDGF,and bFGF.Likewise, we identified tumor-derived injurins as IL-1, PDGF,and bFGF.But mouse mammary tumor cells produced novel HGF-inducer. In contrast, we found that TGF-beta and glucocorticoids are negative regulator of HGF expression.
期刊论文(353)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
K.Matsumoto: "Pleiotropic roles of HGF in mitogenesis,morphogenesis and organ regeneration." Gann Monograph No.42 : Growth Factors : Cell Growth,Morphogenesis and Transformation, 21 (1994)
K.Matsumoto:“HGF 在有丝分裂、形态发生和器官再生中的多效性作用。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
G.Shiota: "Hepatocyte growth factor accelerates liver regeneration and causes a hepatoproliferative disorder in transgenic mice." Hepatology. (in press). (1994)
G.Shiota:“肝细胞生长因子可加速肝脏再生,并导致转基因小鼠出现肝增殖性疾病。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
G.Shiota: "Autocrine stimulation of glioblastoma cells resulting from expression of c-met and the met-ligand(Scatter factor/Hepatocyte growth factor)." Oncogene. (in press). (1994)
G.Shiota:“c-met 和 met-配体(分散因子/肝细胞生长因子)的表达导致胶质母细胞瘤细胞的自分泌刺激。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
J.Wojta: "Hepatocyte growth factor stimulates expression of plasminogen activator inhibitor type 1 and tissue factor in HepG2 cells in culture." Blood. 84. 151-157 (1994)
J.Wojta:“肝细胞生长因子可刺激培养的 HepG2 细胞中 1 型纤溶酶原激活剂抑制剂和组织因子的表达。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
W.G.Jiang: "Inhibition of motility and invasion by invasion inhibiting factor-2 (11F-2) on human colon cancer cells." Surg.Res.Commun.17. 67-78 (1995)
W.G.Jiang:“侵袭抑制因子2(11F-2)对人结肠癌细胞的运动和侵袭的抑制。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 298 条
DISTANCE MEASUREMENTS OF FIBROUS PRION PROTEINS BY PULSE ESR SPECTROSCOPY
-
批准号:24654112
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.5万
-
财政年份:2012
-
负责人:NAKAMURA Toshikazu
-
依托单位:
Analysis of molecular mechanisms that reciprocally regulate growth and differentiation of mature hepatocytes
-
批准号:21390079
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.98万
-
财政年份:2009
-
负责人:NAKAMURA Toshikazu
-
依托单位:
Investigation of Spin Dynamics and Development of Devices for Low-Dimensional Electronic Phases
-
批准号:20340095
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$5.49万
-
财政年份:2008
-
负责人:NAKAMURA Toshikazu
-
依托单位:
Molecular Mechanisms of Tissue Regeneration through the Conversion of HGF Receptor Signaling in Response of Injury
-
批准号:18390087
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.57万
-
财政年份:2006
-
负责人:NAKAMURA Toshikazu
-
依托单位:
Molecular Basis of Anti-fibrosis via Destruction of an Organ Self-repair System
-
批准号:14207005
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$28.87万
-
财政年份:2002
-
负责人:NAKAMURA Toshikazu
-
依托单位:
Investigation of the electronic states in the successive SDW transitions of one-dimensional organic conductors
-
批准号:13640375
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.05万
-
财政年份:2001
-
负责人:NAKAMURA Toshikazu
-
依托单位:
Studies on Tissue Morphogenesis, Organogenesis and Repair by HGF
-
批准号:11308025
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$25.13万
-
财政年份:1999
-
负责人:NAKAMURA Toshikazu
-
依托单位:
Molecular and cellular biological analyzes of morphogenesis modulated by HGF
-
批准号:08408027
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$23.42万
-
财政年份:1996
-
负责人:NAKAMURA Toshikazu
-
依托单位:
Inhibitory effects of HGF antagonist on invasion/metastasis of tumor cells.
-
批准号:07557199
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$4.16万
-
财政年份:1995
-
负责人:NAKAMURA Toshikazu
-
依托单位:
Development of Large Scale Expression, Preparation, and Highly Sensitive Immunoassay Methods for Hepatocyte Growth Factor
-
批准号:03558020
-
项目类别:Grant-in-Aid for Developmental Scientific Research (B)
-
资助金额:$10.18万
-
财政年份:1991
-
负责人:NAKAMURA Toshikazu
-
依托单位:
Study on molecular mechanism of liver regeneration by platelet-derived factors
-
批准号:01440092
-
项目类别:Grant-in-Aid for General Scientific Research (A)
-
资助金额:$20.54万
-
财政年份:1989
-
负责人:NAKAMURA Toshikazu
-
依托单位:
Diagnosis for hepatitis, development of a vaccine for hepatitis virus and development of a new drug for liver diseases using primary culture of human hepatocytes
-
批准号:59870013
-
项目类别:Grant-in-Aid for Developmental Scientific Research
-
资助金额:$6.14万
-
财政年份:1984
-
负责人:NAKAMURA Toshikazu
-
依托单位:
国内基金
海外基金
登录
查看更多内容
金荞麦黄酮靶向抑制c-MET介导的PI3K/Akt和Ras/MAPK通路逆转NSCLC EGFR-TKI耐药的机制研究
-
批准号:2026JJ81256
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:李弘德
-
依托单位:
复方香巴戟膏介导的NO/HGF/c-met通路活化卫星细胞促进损伤后肌肉组织再生
-
批准号:2025JJ70694
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:丁轩
-
依托单位:
安罗替尼通过调控HGF/c-MET信号通路与自噬相互作用促进人脑胶质瘤细胞凋亡的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:刘细帮
-
依托单位:
新型靶向c-MET/EGFR小分子抑制剂ZP-32克服EGFR TKI MET扩增耐药的非小细胞肺癌脑转作用及机制研究
-
批准号:2025JJ70229
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:刘兰
-
依托单位:
基于核酸适体的原位共价标记技术用于精准高效调控
c-Met 蛋白功能
-
批准号:2024JJ6017
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:陈坤
-
依托单位:
靶向 c-Met 放射性诊疗分子的设计合成及评价研究
-
批准号:24ZR1477300
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:瞿春容
-
依托单位:
HGF/c-Met信号通路对脑梗死中血脑屏障的保护作用及机制的研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:刘晖
-
依托单位:
基于CNN-Transformer和对抗迁移学习的NSCLC无创c-MET突变分型诊断及靶向治疗敏感性再分层研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:--
-
批准年份:2024
-
负责人:孙艺歌
-
依托单位:
基于靶标结构的新型AXL/c-Met双靶点抑制剂的设计、合成与抗NSCLC突变活性研究
-
批准号:22367012
-
项目类别:地区科学基金项目
-
资助金额:32.00万元
-
批准年份:2023
-
负责人:朱五福
-
依托单位:
基于功能核酸的新型靶向c-Met受体纳米抑制剂的设计及其肿瘤诊疗研究
-
批准号:2023JJ40211
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:马文杰
-
依托单位: